Approval Times For New Drugs: Does The Source Of Funding For FDA Staff Matter? Carpenter et al. Health Affairs (2003) 10.1377/hlthaff.w3.618
Response by Mary Olson Rejoinder by Daniel Carpenter
© 2001-2009 Project HOPEThe People-to-People Organization Terms and Policies